5 YEAR AND LONG-TERM BUDGET IMPACT ANALYSIS OF NEW HEPATITIS C THERAPIES FROM A PAYER PERSPECTIVE IN SWITZERLAND
Author(s)
Schnyder A
Zürcher Hochschule für Angewandte Wissenschaften, Winterthur, Switzerland
Presentation Documents
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PGI16
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Gastrointestinal Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now